{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:28:42Z","timestamp":1767846522967,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12028-020-00915-5","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:57:37Z","timestamp":1580252257000},"page":"508-515","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Beta-Blockade in Aneurysmal Subarachnoid Hemorrhage: a Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8302-7097","authenticated-orcid":false,"given":"Aravind V.","family":"Ramesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charis F. K.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Mounstephen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Crewdson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"issue":"3","key":"915_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMcp1605827","volume":"377","author":"MT Lawton","year":"2017","unstructured":"Lawton MT, Vates GE. Subarachnoid hemorrage. N Engl J Med. 2017;377(3):257\u201366.","journal-title":"N Engl J Med"},{"issue":"10069","key":"915_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0140-6736(16)30668-7","volume":"389","author":"RL Macdonald","year":"2017","unstructured":"Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655\u201366.","journal-title":"Lancet"},{"issue":"4","key":"915_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","volume":"10","author":"GJE Rinkel","year":"2011","unstructured":"Rinkel GJE, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2011;10(4):349\u201356.","journal-title":"Lancet Neurol"},{"key":"915_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1478-7547-8-6","volume":"8","author":"O Rivero-Arias","year":"2010","unstructured":"Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc. 2010;8:6.","journal-title":"Cost Eff Resour Alloc"},{"key":"915_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11910-017-0716-3","volume":"1","author":"R Garg","year":"2017","unstructured":"Garg R, Bar B. Systemic complications following aneurysmal subarachnoid hemorrhage. Curr Neurol Neurosci Rep. 2017;1:7.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"915_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.wneu.2017.10.016","volume":"109","author":"A Hall","year":"2018","unstructured":"Hall A, O\u2019Kane R. The extracranial consequences of subarachnoid hemorrhage. World Neurosurg. 2018;109:381\u201392.","journal-title":"World Neurosurg"},{"key":"915_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13054-015-1036-0","volume":"19","author":"H Lantigua","year":"2015","unstructured":"Lantigua H, Ortega-Gutierrez S, Schmidt JM, et al. Subarachnoid hemorrhage: who dies, and why? Crit Care. 2015;19:309.","journal-title":"Crit Care"},{"issue":"7","key":"915_CR8","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1212\/01.wnl.0000342471.07290.07","volume":"72","author":"IAC Van Der Bilt","year":"2009","unstructured":"Van Der Bilt IAC, Hasan D, Vandertop WP, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology. 2009;72(7):635\u201342.","journal-title":"Neurology"},{"issue":"5","key":"915_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1179\/1743132812Y.0000000033","volume":"34","author":"T Ogura","year":"2012","unstructured":"Ogura T, Satoh A, Ooigawa H, et al. Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage. Neurol Res. 2012;34(5):484\u201390.","journal-title":"Neurol Res"},{"issue":"3","key":"915_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12028-012-9673-5","volume":"16","author":"M Moussouttas","year":"2012","unstructured":"Moussouttas M, Lai EW, Khoury J, Huynh TT, Dombrowski K, Pacak K. Determinants of central sympathetic activation in spontaneous primary subarachnoid hemorrhage. Neurocrit Care. 2012;16(3):381\u20138.","journal-title":"Neurocrit Care"},{"issue":"8","key":"915_CR11","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00701-013-1725-x","volume":"155","author":"M Moussouttas","year":"2013","unstructured":"Moussouttas M, Bhatnager M, Huynh TT, et al. Association between sympathetic response, neurogenic cardiomyopathy, and venous thromboembolization in patients with primary subarachnoid hemorrhage. Acta Neurochir (Wien). 2013;155(8):1501\u201310.","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"915_CR12","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/STROKEAHA.112.658153","volume":"43","author":"GM Ibrahim","year":"2012","unstructured":"Ibrahim GM, MacDonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012;43(8):2102\u20137.","journal-title":"Stroke"},{"issue":"3","key":"915_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s12028-013-9909-z","volume":"20","author":"JM Schmidt","year":"2014","unstructured":"Schmidt JM, Crimmins M, Lantigua H, et al. Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage. Neurocrit Care. 2014;20(3):390\u20138.","journal-title":"Neurocrit Care"},{"issue":"2","key":"915_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12028-012-9804-z","volume":"18","author":"T Okabe","year":"2013","unstructured":"Okabe T, Kanzaria M, Rincon F, Kraft WK. Cardiovascular protection to improve clinical outcomes after subarachnoid hemorrhage: is there a proven role? Neurocrit Care. 2013;18(2):271\u201384.","journal-title":"Neurocrit Care"},{"issue":"3","key":"915_CR15","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3171\/2015.7.JNS15956","volume":"125","author":"N Chalouhi","year":"2016","unstructured":"Chalouhi N, Daou B, Okabe T, et al. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: a cohort study. J Neurosurg. 2016;125(3):730\u20136.","journal-title":"J Neurosurg"},{"issue":"1","key":"915_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4037\/ajcc2014326","volume":"23","author":"E Crago","year":"2014","unstructured":"Crago E, Kerris K, Kuo C, et al. Cardiac abnormalities after aneurysmal subarachnoid hemorrhage: effects of \u03b2-blockers and angiotensin-converting enzyme inhibitors. Am J Crit Care. 2014;23(1):30\u20139.","journal-title":"Am J Crit Care"},{"key":"915_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clineuro.2017.04.022","volume":"158","author":"H Luo","year":"2017","unstructured":"Luo H, Song W-X, Jiang J-W, Zhao J-L, Rong W-L, Li M-H. Effects of preadmission beta-blockers on neurogenic stunned myocardium after aneurysmal subarachnoid hemorrhage: a meta- analysis. Clin Neurol Neurosurg. 2017;158:77\u201381.","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"915_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312.","journal-title":"J Clin Epidemiol"},{"key":"915_CR19","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]. Cochrane Collab 2011."},{"key":"915_CR20","volume-title":"The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"G Wells","year":"2000","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J. The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2000."},{"issue":"13","key":"915_CR21","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/sim.2287","volume":"25","author":"Pietrantonj C Di","year":"2006","unstructured":"Di Pietrantonj C. Four-fold table cell frequencies imputation in meta analysis. Stat Med. 2006;25(13):2299\u2013322.","journal-title":"Stat Med"},{"key":"915_CR22","unstructured":"The Nordic Cochrane Centre. Review Manager (RevMan). Cochrane Collab. 2014."},{"key":"915_CR23","first-page":"326e","volume":"31","author":"KW McConeghy","year":"2011","unstructured":"McConeghy KW, Tesoro EP, Mucksavage JJ, Kim KS. Effect of home b-blocker use in patients presenting with subarachnoid hemorrhage. Pharmacotherapy. 2011;31:326e.","journal-title":"Pharmacotherapy"},{"key":"915_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF00543706","volume":"28 Suppl C","author":"G Neil-Dwyer","year":"1985","unstructured":"Neil-Dwyer G, Walter P, Cruickshank JM. Beta-blockade benefits patients following a subarachnoid haemorrhage. Eur J Clin Pharmacol. 1985;28 Suppl C:25\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"915_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0090-3019(86)90287-9","volume":"25","author":"G Neil-Dwyer","year":"1986","unstructured":"Neil-Dwyer G, Cruickshank J, Stratton C. Beta-blockers, plasma total creatine kinase and creatine kinase myocardial isoenzyme, and the prognosis of subarachnoid hemorrhage. Surg Neurol. 1986;25(2):163\u20138.","journal-title":"Surg Neurol"},{"issue":"6143 CC-Stroke","key":"915_CR26","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1136\/bmj.2.6143.990","volume":"2","author":"G Neil-Dwyer","year":"1978","unstructured":"Neil-Dwyer G, Walter P, Cruickshank JM, Doshi B, O\u2019Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978;2(6143 CC-Stroke):990\u20132.","journal-title":"Br Med J"},{"key":"915_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12883-015-0279-3","volume":"15","author":"J Sundb\u00f8ll","year":"2015","unstructured":"Sundb\u00f8ll J, Schmidt M, Horv\u00e1th-Puh\u00f3 E, et al. Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study. BMC Neurol. 2015;15:24.","journal-title":"BMC Neurol"},{"issue":"3","key":"915_CR28","first-page":"141","volume":"24","author":"ML Wang","year":"1991","unstructured":"Wang ML. A random sample study of therapeutic effect of beta-receptor blocking agents in patients with subarachnoid hemorrhage. Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1991;24(3):141.","journal-title":"Zhonghua Shen Jing Jing Shen Ke Za Zhi"},{"issue":"1\u20134 CC-Stroke","key":"915_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF01405881","volume":"34","author":"MM Cameron","year":"1976","unstructured":"Cameron MM, Haas RH. Adrenergic blockade in subarachnoid haemorrhage. Acta Neurochir (Wien). 1976;34(1\u20134 CC-Stroke):261\u20134.","journal-title":"Acta Neurochir (Wien)"},{"issue":"1","key":"915_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1874205X01610010155","volume":"10","author":"MM Chang","year":"2016","unstructured":"Chang MM, Raval RN, Southerland JJ, et al. Beta blockade and clinical outcomes in aneurysmal subarachnoid hemorrhage. Open Neurol J. 2016;10(1):155\u201363.","journal-title":"Open Neurol J"},{"key":"915_CR31","first-page":"S241","volume":"19","author":"K Duello","year":"2013","unstructured":"Duello K, Nagel J, Freeman W, Blackshear J, Miller D. Effect of use of beta-blockers, statins, and inhibitors of the renin-angiotensin system prior to subarachnoid hemorrhage on mortality. Neurocrit Care. 2013;19:S241.","journal-title":"Neurocrit Care"},{"issue":"3\u20134 CC-Stroke C","key":"915_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF01809261","volume":"121","author":"G Hamann","year":"1993","unstructured":"Hamann G, Haass A, Schimrigk K. Beta-blockade in acute aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1993;121(3\u20134 CC-Stroke CC-Hypertension):119\u201322.","journal-title":"Acta Neurochir (Wien)"},{"key":"915_CR33","first-page":"S16","volume":"13","author":"S Jain","year":"2010","unstructured":"Jain S, John S, Patel P, Prabakaran S, Bleck T, Temes R. Premorbid beta-blocker use is associated with a reduced likelihood of neurogenic stunned myocardium following aneurysmal subarachnoid hemorrhage (ASAH). Neurocrit Care. 2010;13:S16.","journal-title":"Neurocrit Care"},{"issue":"3","key":"915_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/ANA.0b013e3181d0c2e4","volume":"22","author":"M Kawaguchi","year":"2010","unstructured":"Kawaguchi M, Utada K, Yoshitani K, et al. Effects of a short-acting \u03b21 receptor antagonist landiolol on hemodynamics and tissue injury markers in patients with subarachnoid hemorrhage undergoing intracranial aneurysm surgery. J Neurosurg Anesthesiol. 2010;22(3):230\u20139.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"5","key":"915_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.10.006","volume":"22","author":"CW Liang","year":"2013","unstructured":"Liang CW, Chen R, Macri E, Naval N. Preadmission beta-blockers are associated with decreased incidence of neurogenic stunned myocardium in aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2013;22(5):601\u20137.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"915_CR36","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.wneu.2015.01.013","volume":"83","author":"AN Malik","year":"2015","unstructured":"Malik AN, Gross BA, Rosalind Lai PM, Moses ZB, Du R. Neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2015;83(6):880\u20135.","journal-title":"World Neurosurg"},{"issue":"6","key":"915_CR37","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002286","volume":"266","author":"AS Alali","year":"2017","unstructured":"Alali AS, Mukherjee K, McCredie VA, et al. Beta-blockers and traumatic brain injury: a systematic review, meta-analysis, and eastern association for the surgery of trauma guideline. Ann Surg. 2017;266(6):952\u201361.","journal-title":"Ann Surg"},{"issue":"1","key":"915_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aew095","volume":"117","author":"M Veldeman","year":"2016","unstructured":"Veldeman M, H\u00f6llig A, Clusmann H, et al. Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review. Br J Anaesth. 2016;117(1):17\u201340.","journal-title":"Br J Anaesth"},{"issue":"9627","key":"915_CR39","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","volume":"371","author":"PJ Devereaux","year":"2008","unstructured":"Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet. 2008;371(9627):1839\u201347.","journal-title":"Lancet"},{"issue":"1","key":"915_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury. Fourth Edn Neurosurg. 2017;80(1):6\u201315.","journal-title":"Fourth Edn Neurosurg"},{"issue":"6","key":"915_CR41","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association\/american stroke association. Stroke. 2012;43(6):1711\u201337.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-020-00915-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00915-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:17:51Z","timestamp":1611706671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-020-00915-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-00915-5","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"28 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval or informed consent was needed for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}